Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jan 22:16:20.
doi: 10.1186/s12879-016-1339-z.

Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe

Lynn Sodai Zijenah  1 , Gerard Kadzirange  2 , Tsitsi Bandason  3 , Maria Mary Chipiti  4 , Bevel Gwambiwa  5 , Forget Makoga  6 , Pauline Chungu  7 , Philip Kaguru  8 , Keertan Dheda  9
Affiliations
Randomized Controlled Trial

Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe

Lynn Sodai Zijenah et al. BMC Infect Dis. .

Abstract

Background: In Zimbabwe, sputum smear microscopy (SSM) is the routinely used TB diagnostic tool in hospitalised HIV-infected patients. However, SSM has poor sensitivity in HIV-infected patients. We compared performance of urine lipoarabinomannan strip test (LAM) and SSM among hospitalized HIV-infected patients with suspected TB.

Methods: Hospitalized HIV-infected patients with suspected TB were randomized to LAM plus SSM or SSM alone groups as part of a larger multi-country parent study. Here we present a comparison of LAM versus SSM performance from the Zimbabwe study site. LAM analyses (grade 2 cut-off) were conducted using (i) a microbiological reference standard (MRS; culture positivity for M.tb and designated definite TB) and (ii) a composite reference standard (CRS; definite TB plus probable TB i.e. patients with clinical TB excluded from the culture negative group). CRS constituted the primary analysis.

Results: 82/457 (18%) of the patients randomized to the LAM group were M.tuberculosis culture positive. Using CRS, sensitivity (%, 95% CI) of LAM was significantly higher than SSM [49.2 (42.1-56.4) versus 29.4(23.2-36.3); p < 0.001]. Specificity and PPV were 98.1%, and 95.8%, respectively. By contrast, using MRS, LAM sensitivity was similar to SSM and specificity was significantly lower, however, the combined sensitivity of LAM and SSM was significantly higher than that of SSM alone, p = 0.009. Using CRS, LAM sensitivity (%, CI) was CD4 count dependent [60.6(50.7-69.8) at ≤50 cells/μL; 40.0(22.7-59.4) at 51-100 cells/μL, and 32.8(21.0-46.3) at >100 cells/μL. The combined sensitivity of LAM and SSM was higher than SSM alone being highest at CD4 counts <50 cells/μL [67.6(57.9-76.3); p = <0.001]. Specificity of LAM or SSM alone, or of combined LAM and SSM was >97% in all the 3 CD4 strata.

Conclusion: Among hospitalized HIV-infected patients with suspected TB, the sensitivity of LAM is significantly higher than that of SSM, especially at low CD4 counts. LAM and SSM are complimentary tests for diagnosis of TB in HIV-infected patients. We recommend a combination of LAM and SSM for TB diagnosis in HIV-infected patients with low CD4 counts in HIV/TB co-endemic countries, where alternative methods are unavailable.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Participants Flow. Flow chart of study participants and analysis. LAM = urine Lipoarabinomannan strip test; SSM = sputum smear microscopy
Fig. 2
Fig. 2
Comparative sensitivity of SSM versus LAM; and the combination of SSM and LAM versus SSM alone using composite reference standard stratified by CD4 counts. SSM; sputum smear microscopy; LAM; urine Lipoarabinomannan strip test. a P-value indicates significant differences between SSM only and LAM only. bP-value indicates significant differences between SSM only and SSM plus LAM
See this image and copyright information in PMC

References

    1. Dheda K, Barry CE 3rd, Maartens G. Tuberculosis. Lancet. 2015, Sep 11. [Epub ahead of print].
    1. Getahun H, Harrington M, O’Brien R, Nunn P. Diagnosis of smear negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042–2049. doi: 10.1016/S0140-6736(07)60284-0. - DOI - PubMed
    1. Lawn SD, Dheda K, Kerkhoff AD, Peter JG, Dorman S, Boehme CC, et al. Determine RB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendation on the design and reporting of clinical studies. BMC Infect Dis. 2013;13:407. doi: 10.1186/1471-2334-13-407. - DOI - PMC - PubMed
    1. Peter J, Theron G, van Zyl-Smit R, Haripersad A, Mottay L, Kraus S, et al. Diagnostic accuracy of a urine lipoarabinomannan strip test for TB detection in HIV-hospitalised patients. Eur Resp J. 2012;40:1211–1220. doi: 10.1183/09031936.00201711. - DOI - PMC - PubMed
    1. Lawn SD, Kerhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis. 2012;12:201–209. doi: 10.1016/S1473-3099(11)70251-1. - DOI - PMC - PubMed

Publication types